FYCOMPA is indicated for: treatment of partial-onset seizures (POS) with or without secondarily generalised seizures in patients from 4 years of age and older.
Adjunctive treatment of primary generalised tonic-clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalised epilepsy (IGE) (see Pharmacology: Pharmacodynamics under Actions).